Please disable your adblock and script blockers to view this page

Medicare Will Not Fully Cover Aduhelm, the Controversial?and Costly?Alzheimer's Disease Drug


Medicare
the Centers for Medicare
Medicaid Services
Biogen
Aduhelm
the Food and Drug Administration
Health and Human Services


Xavier Becerra

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     36.00%   
   Negativity   64.00%
The New York Times
SOURCE: http://time.com/6138635/medicare-aduhelm-alzheimers-drug-coverage/
Write a review: Time
Summary

On Jan. 11, Medicare and Medicaid said it will limit coverage for Aduhelm, the expensive and controversial Alzheimer's drug from Biogen.

As said here by RICARDO ALONSO-ZALDIVAR / AP